Health
Drug combination could make curative surgery possible for some liver cancer patients – News-Medical.net
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible…
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Results published July 29 in the journal…
Continue Reading